Methods Prohibited In Competition
If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.
M1. Manipulation of Blood and Blood Components
The following are prohibited:
- The administration or reintroduction of any quantity of autologous, homologous or heterologous blood or red blood cell products of any origin into the circulatory system.
- Artificially enhancing the uptake, transport or delivery of oxygen, including, but not limited to, perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products (e.g. haemoglobin-based blood substitutes, microencapsulated haemoglobin products), excluding supplemental oxygen.
- Any form of intravascular manipulation of the blood or blood components by physical or chemical means.
M2. Chemical and Physical Manipulation
The following are prohibited:
- Tampering, or attempting to tamper, in order to alter the integrity and validity of Samples collected during Doping Control. These include but are not limited to urine substitution and/or adulteration (e.g. proteases).
- Intravenous infusions and/or injections of more than 50 mL per 6 hour period except for those legitimately received in the course of hospital admissions or clinical investigations.
M3. Gene Doping
The following, with the potential to enhance sport performance, are prohibited:
- The transfer of polymers of nucleic acids or nucleic acid analogues;
- The use of normal or genetically modified cells.
If a Substance or Method is not found, please verify with your Anti-Doping Organization to ensure that this Substance or Method is not prohibited as a related Substance or Method that falls under an existing category.
